FDA Clears Abbott Device for Minimally Invasive Heart Valve Leak Repair
The FDA has approved Abbott's Amplatzer Paraclose PVL Occluder, a transcatheter device for treating paravalvular leaks. This marks the first U.S. approval for a minimally invasive option, offering an alternative to repeat open-heart surgery for patients experiencing blood backflow around surgical heart valves. It represents a significant advancement in cardiac care.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.
Open NewsSnap.ai